கெல்லி கல்வெல் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Saundra Pelletier is marketing a new form of birth control to women wary of hormones. Ms. Pelletier’s back is tattoed with feminist symbols.Credit.Michelle Groskopf for The New York Times June 10, 2021, 3:00 a.m. ET SAN DIEGO If you’re a woman aged 18 to 34, you may have seen a Phexxi ad during a commercial break on Hulu. Or you could have come across the product a non-hormonal contraceptive gel that women can use within an hour before having sex while scrolling through Instagram, somewhere between a recipe for Paleo bagels and an ode to body positivity. Phexxi went on sale in September in the United States, after receiving approval from the Food and Drug Administration. Prescriptions for Phexxi are in the low thousands, according to its publicly traded parent company, Evofem about 17,280. This is puny compared to the estimated 8.6 million women who have undergone female sterilization or the 6.6 million women on the Pill.

New yorkUnited statesRush universityMarie curieMichelle groskopfRuth bader ginsburgMeera shahKelly culwellErin turnerSaundra pelletierRosa parksCenters for diseaseWorld health organizationDrug administrationHusson university in bangorNew york times